Disclosed herein are pharmaceutical compositions of the compound N-(4-{ [6,7-bis(methoxyquinolin-4-yl]oxy} phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide and the (L)-malate salt thereof, wherein the formation of 6,7-dimethoxy-quinoline-4-ol in the pharmaceutical formulation is minimized to 50 ppm or less over time.